Insomnia Disorder Clinical Trials

21 recruiting

Insomnia Disorder Trials at a Glance

14 actively recruiting trials for insomnia disorder are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Beijing, Guangzhou, and Chongqing. Lead sponsors running insomnia disorder studies include Shanghai Haiyan Pharmaceutical Technology Co., Ltd., Laval University, and Idaho State University.

Browse insomnia disorder trials by phase

Treatments under study

About Insomnia Disorder Clinical Trials

Looking for clinical trials for Insomnia Disorder? There are currently 21 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Insomnia Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Insomnia Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Not Applicable

Optimizing an Integrated Mind and Body Treatment for Insomnia: The SLEEPS Study 2

Insomnia Disorder
University of California, San Francisco40 enrolled1 locationNCT07036705
Recruiting
Phase 4

Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease

SleepAlzheimer DiseaseInsomnia Disorder
University Hospital, Montpellier62 enrolled1 locationNCT05924425
Recruiting
Not Applicable

Brief Behavioral Treatment for Insomnia in Veterans With Posttraumatic Stress Disorder

Insomnia DisorderPosttraumatic Stress Disorder
VA Office of Research and Development200 enrolled1 locationNCT05780177
Recruiting
Not Applicable

Comparing Acoustic Resonance Therapy (ART) vs. Cognitive Behavioral Therapy for Insomnia (CBT-I)

Chronic Insomnia Disorder
Mayo Clinic60 enrolled1 locationNCT07486882
Recruiting
Not Applicable

Mental Imagery and Targeted Memory Reactivation in Insomnia

Insomnia Disorder
University Hospital, Geneva120 enrolled1 locationNCT06335784
Recruiting

Translation and Validation of the French Version of the Sleep Regularity Questionnaire: a New Tool to Address the the Challenge of Sleep Health

Circadian Rhythm DisordersChronic Insomnia Disorder
University Hospital, Bordeaux50 enrolled1 locationNCT06727448
Recruiting
Phase 3

Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder

Insomnia Disorder
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.60 enrolled16 locationsNCT06975514
Recruiting
Not Applicable

The Sleep Clinic Outcome and Practice Study

Insomnia DisorderCircadian Rhythm Sleep Disorder
St. Olavs Hospital3,400 enrolled1 locationNCT06669507
Recruiting
Not Applicable

Impact of Analytic-integrative Cognitive Behavioural Therapy on Acute Insomnia Disorder (Stress)

Acute Insomnia Disorder
Xuanwu Hospital, Beijing70 enrolled1 locationNCT06967922
Recruiting
Phase 3

Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia

Insomnia Disorder
Vanda Pharmaceuticals420 enrolled3 locationsNCT06953869
Recruiting
Not Applicable

Efficacy of CBT-I and Lemborexant Medication for Different Subtypes of Chronic Insomnia

Insomnia Disorder
Laval University90 enrolled1 locationNCT06779149
Recruiting
Not Applicable

Comparative Efficacy of BRT and CBT-I for Insomnia

InsomniaInsomnia DisorderInsomnia Chronic+4 more
Christoph Nissen160 enrolled2 locationsNCT06767137
Recruiting
Not Applicable

Assessing Modified CBTi in Adults with Insomnia Disorder

Insomnia Disorder
Idaho State University40 enrolled1 locationNCT06600516
Recruiting
Phase 3

Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder

Insomnia Disorder
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.1,041 enrolled88 locationsNCT05525637